Command Palette

Search for a command to run...

Clinical Trials · NCT01753362

Liraglutide In Overweight Patients With Type 1 Diabetes

CompletedPhase 3Liraglutide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
University at Buffalo
Enrollment
84
Start date
Dec 2012
Locations
2 sites, United States
Primary endpoint
HbA1c
View Liraglutide compound reference